0001493152-23-041691.txt : 20231116 0001493152-23-041691.hdr.sgml : 20231116 20231116164511 ACCESSION NUMBER: 0001493152-23-041691 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUM MARK L CENTRAL INDEX KEY: 0001274282 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 231415226 MAIL ADDRESS: STREET 1: C/O IMPRIMIS PHARMACEUTICALS, INC STREET 2: 12264 EL CAMINO REAL, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: HARROW HEALTH, INC. DATE OF NAME CHANGE: 20181228 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 4 1 ownership.xml X0508 4 2023-11-16 0 0001360214 HARROW, INC. HROW 0001274282 BAUM MARK L C/O HARROW HEALTH, INC. 102 WOODMONT BLVD, SUITE 610 NASHVILLE TN 37205 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-11-16 4 P 0 7500 8.11 A 2022961 D These shares were purchased in a single transaction at a price of $8.1097. /s/ Mark L Baum 2023-11-16